Palonosetron hydrochloride for the prevention of chemotherapy-induced nausea and vomiting.
about
Randomized pharmacokinetic study comparing subcutaneous and intravenous palonosetron in cancer patients treated with platinum based chemotherapy.Pilot study on the efficacy of an ondansetron- versus palonosetron-containing antiemetic regimen prior to highly emetogenic chemotherapyEconomic evaluation of 5-HT3 receptor antagonists in combination with dexamethasone for the prevention of 'overall' nausea and vomiting following highly emetogenic chemotherapy in Chinese adult patients.Prevention and management of chemotherapy-induced nausea and vomiting.Palonosetron and prednisolone for the prevention of nausea and emesis during fractionated radiotherapy and 5 cycles of concomitant weekly cisplatin-a phase II study.
P2860
Palonosetron hydrochloride for the prevention of chemotherapy-induced nausea and vomiting.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Palonosetron hydrochloride for ...... y-induced nausea and vomiting.
@en
Palonosetron hydrochloride for ...... y-induced nausea and vomiting.
@nl
type
label
Palonosetron hydrochloride for ...... y-induced nausea and vomiting.
@en
Palonosetron hydrochloride for ...... y-induced nausea and vomiting.
@nl
prefLabel
Palonosetron hydrochloride for ...... y-induced nausea and vomiting.
@en
Palonosetron hydrochloride for ...... y-induced nausea and vomiting.
@nl
P2860
P356
P1476
Palonosetron hydrochloride for the prevention of chemotherapy-induced nausea and vomiting
@en
P2093
Jørn Herrstedt
P2860
P304
P356
10.1586/ERA.09.175
P577
2010-02-01T00:00:00Z